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This work reports a genetic analysis of the interac-
tions betweenNahR, the LysR-type regulator of the NAH
operons for biodegradation of naphthalene in Pseudo-
monas, and its aromatic effectors. Six mutants encoding
NahR variants responsive to salicylate analogs such as
benzoate, which is not an inducer for the wild type reg-
ulator, were isolated with a polymerase chain reaction-
based saturation mutagenesis protocol. Most mutants
displaying a specific change of effector profile bore sin-
gle amino acid substitutions within a short protein seg-
ment of 60 residues located at the central portion of the
NahR sequence. Some of the protein variants exhibited
an increased affinity for salicylate and also for other-
wise suboptimal effectors, with apparent Ks
* values
5–100-fold lower than those of the wild type NahR pro-
tein. In addition, all mutants were activated by inducers
bearing novel substituents at positions 1 or 2 of the
aromatic ring and displayed also an enhanced tolerance
to changes at positions 3 and 4. Correlation between
mutations in NahR and the structures of the new effec-
tors suggested that protein sites Met116, Arg132, Asn169,
and Arg248 are involved in effector recognition and bind-
ing during the earlier steps of the process leading to
transcriptional activation of cognate NAH promoters.
Transcriptional regulators belonging to the LysR-type family
(hereafter referred to as LTTRs)1 have protein sizes ranging
from 276 to 324 amino acids, and they are widely distributed
among prokaryotes (1). Individual members of the family share
their being responsive to chemical effectors, their being tran-
scribed divergently from the genes that they regulate (fre-
quently accompanying an autorepression mechanism), and
their mode of transcriptional activation of target promoters. All
LTTRs studied so far in this respect remain bound to equiva-
lent promoter-proximal target DNA sequences regardless of
the presence or absence of inducer. Effector binding and sub-
sequent transcriptional activation seem to result in the relief of
the DNA bending caused by LTTR binding under noninduced
conditions (reviewed in Ref. 2). In fact, the most conserved
portion of LTTRs is precisely the N-terminal segment that
contains the helix-turn-helix DNA-binding motif that accounts
for binding to DNA (3).
Apart from changes in DNA structure, the precise mecha-
nism by which inducer binding is ultimately translated in
transcriptional activation remains largely unknown. LTTRs
contain a poorly conserved central domain (see Fig. 1) believed
to interact with the chemical inducers. The divergence of the
central portions of LTTRs seems to reflect the variety of induc-
ers to which these proteins respond (1). This notion is sup-
ported by comparisons between various NodD proteins of Rhi-
zobium species. These LTTRs are similar and bind the same
target DNA sequences, but minor differences in their central
domain account for their responsiveness to distinct flavonoid
derivatives (4, 5). Furthermore, constitutive, inducer-inde-
pendent mutants of various LTTRs have been found to bear
changes in their central domain (6–9). However, evidence of
direct interactions between specific residues of LTTRs and
their cognate inducers is generally scarce. A particularly useful
LTTR to address this issue is the NahR protein of Pseudomo-
nas, the salicylate-responsive transcriptional regulator of two
operons for biodegradation of naphthalene by strains carrying
the catabolic plasmid NAH7 (Refs. 1, 3, and 10; see Fig. 1).
Because the native effector of NahR is a simple aromatic com-
pound, an entire variety of salicylate analogs is commercially
available to search for altered effector specificities. In this work,
we show that mutations at the central domain of NahR expand
the range of aromatic compounds that can activate the protein
into a transcriptionally competent form. On the basis of these
results, we have identified a region of the NahR protein that may
interact with the aromatic inducers and tentatively pinpoint
those amino acid residues involved in effector specificity.
MATERIALS AND METHODS
Strains, Plasmids, Media, and General Procedures—The bacterial
strains and plasmids used in this work are listed in Table I. Plasmids
bearing an R6K origin of replication (i.e. mini-Tn5 delivery vectors)
were always propagated in Escherichia coli CC118lpir. Bacteria were
grown in rich LB medium (11) supplemented where required with 150
mg/ml ampicillin (Ap), 50 mg/ml kanamycin (Km), 25 mg/ml streptomy-
cin (Sm), and 40 mg/ml 5-bromo-4-chloro-3-indolyl b-D-galactopyrano-
side (X-Gal). Recombinant DNA techniques were made following pub-
lished protocols (12). Insertion of hybrid mini-transposons into the
chromosome of target bacteria was made as described in detail else-
where (13) using E. coli S17–1lpir as the donor strain of suicide deliv-
ery plasmids. DNA sequencing of NahR variants was carried out on
double-stranded templates with an automatic Applied Biosystems in-
strument and a dye terminator cycle protocol with Taq polymerase.
Construction and Analysis of Reporter Strains—Activity of NahR was
monitored in all cases by following its ability to cause accumulation of
b-galactosidase in an E. coli strain bearing a transcriptional Psal::lacZ
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fusion. To this end, a hybrid between nahG (the first gene transcribed
from Psal; see Fig. 1) and lacZ was made by cloning a 0.5-kb SalI-PstI
fragment of pMS15 (spanning the Psal promoter; Ref. 3) in the corre-
sponding sites of lacZ vector pNM482 plasmid (14). This fused the first
70 codons of nahG to the eighth codon of lacZ. The same fusion was
recloned in pUJ9 (13) by exchange of EcoRI-SacI segments between the
two plasmids. The entire Psal::nahG9-9lacZ fusion (simplified,
Psal::lacZ) was then excised as a NotI fragment from the resulting
plasmid and placed into the NotI site of pUT/mini-Tn5Sm (15). This
gave rise to pTSAL1, a delivery vector for a hybrid mini-transposon
bearing the Psal::lacZ fusion, which was placed into the chromosome of
E. coli CC118 as explained in de Lorenzo and Timmis (13). Such an
arrangement places strong transcriptional terminators upstream and
downstream of the reporter cassette (see Fig. 1) to prevent readthrough
transcription from nearby chromosomal promoters after insertion. The
resulting strain (E. coli SAL1) was used as the recipient of plasmids
bearing the nahR variants as described below. Induction of the Psal
promoter in E. coli cells bearing Psal::lacZ fusions was made by growing
the corresponding cultures in LB medium at 37 °C up to an A600 of 0.4,
after which inducers were added at the concentrations indicated in each
case. Incubation was then continued for 5 h, and the accumulation of
b-galactosidase was measured in cells permeabilized with chloroform
and sodium dodecyl sulfate as described by Miller (11). b-Galactosidase
activity values given throughout this paper represent the average of at
least three independent experiments, each of which was conducted in
duplicate samples, with deviations being less than 15–20%.
Mutagenesis of the nahR Gene—The plasmid pNR, used as the DNA
template for the protocol described below, was produced by transferring
an 1.2-kb NcoI-HindIII fragment from pMS15 (3) bearing the entire
nahR sequence to the same sites of vector pFH2 (16). For mutagenesis,
the DNA regions of interest within pNR were amplified with the po-
lymerase chain reaction (PCR) using the oligos NRBgl (59-ACCGACAT-
TGGCGAGATCT-39) and NRSph (59-CTTGTGGTACTTCGCATGC-39)
under conditions favoring errors of the Taq DNA polymerase. 100-ml
PCR reactions were set up in a buffer containing 0.1 mM MgCl2, 0.5 mM
MnCl2, 1 mM dGTP, 1 mM dTTP, 1 mM dCTP, 0.25 mM dATP, 0.5 mg of
each of the primers, and 5 units of Taq DNA polymerase. 1–50 ng of
pNR template was added to the reactions, the amount depending on the
rate of mutations desired. The resulting 0.6-kb amplification products
were digested with BglII and SphI, purified, and used to replace the
equivalent segment of pNR. A second DNA template, namely plasmid
pUC/NR, was alternatively employed for mutagenesis of a different
nahR portion (see Fig. 2). pUC/NR bears also the entire nahR gene
assembled as the result of a tripartite ligation between NotI-digested
pUC18Not (17), a 0.6-kb NotI-BglII fragment of pUC/NRC (see Table I)
and a 0.4-kb BglII-NotI fragment of pNR. pUC/NR has an unique
HindIII site that simplifies insertion when required of the 0.6-kb Hin-
dIII-SphI segment of nahR sequence resulting from error-prone PCR
with primers NRH5 (59-ATCTGGCCGAGCCCGTC-39) and NRSph. As
before, the mutated HindIII-SphI DNA segments were purified and
cloned in the same sites of the larger fragment of pUC/NR. After
mutagenesis, screening for NahR variants with altered effector speci-
ficity included the individual culture of each of the E. coli SAL1 trans-
formants with the reconstructed nahR1 plasmids in microtiter plates,
followed by their replication on separate LB plates amended with Ap,
X-Gal, and 1 mM of each of the aromatic compounds under scrutiny.
Differences in the intensity of the color developed in equivalent spots in
each plate after incubation was considered an indication of altered
NahR activity.
Construction of nahR/Psal-lacZ Insertions—Mini-Tn5 derivatives
bearing not only a Psal-lacZ fusion but also the mutant nahR variants
named nahR3 and nahR4 were made as follows. pNR derivatives en-
coding the mutated genes (pNR3 and pNR4, respectively) were partially
digested with HindIII and ligated to a 2.1-kb HindIII V-Km fragment
(18). The location and orientation selected was the same than that
present in the reference wild type nahR/Psal-lacZ mini-transposon
bore by pCNB4lacZ plasmid (Ref. 19; see Fig. 1). The resulting plasmids
(pNR3Km and pNR4Km, respectively) were then digested with NcoI,
which produced 2.2-kb DNA fragments spanning the entire mutant
nahR sequence and part of the V-Km fragment. The equivalent NcoI
segment pCNB4lacZ was then replaced by each of theseNcoI segments,
thus replacing the wild type nahR sequence by the mutant variants and
reconstructing V-Km interposon. These manipulations originated
transposon delivery plasmids pCNB43lacZ and pCNB44lacZ that carry
hybrid mini-transposons containing nahR3/Psal-lacZ and nahR4/Psal-
lacZ reporter elements, respectively. Once inserted into the chromosome
of E. coli CC118 (Table I), the accumulation of b-galactosidase by cells
exposed to aromatic inducers was carried out as described above.
RESULTS
Structural Requirements of NahR Effectors—In order to de-
termine which specific portions of the salicylate molecule were
engaged in activation of NahR, we examined the degree of
structural permissiveness of the regulator toward structural
variants of the natural inducer. To this end, we assembled the
entire segment of the NAH7 plasmid that spans the wild type
nahR gene and adjacent regions in a mini-Tn5 transposon
vector (Fig. 1), thereby faithfully reconstructing in E. coli all
the regulatory elements that participate in the activation of the
Psal promoter in Pseudomonas. In this construct, nahR is
expressed under its own promoter and transcribed divergently
from the Psal promoter, followed by a promoterless lacZ re-
porter gene (Fig. 1). This element was then placed into the
chromosome of E. coli, and the resulting strain (E. coli RSL9)
was challenged with a variety of aromatic compounds as de-
scribed under “Materials and Methods.” Reproduction of the
system in E. coli prevented any metabolism of the aromatic
compounds leading to other intermediates than those added to
the culture and ensured their transport to the cell cytoplasm
through a broad specificity facilitated diffusion system (20).
The results of measuring accumulation of b-galactosidase
under the different inducers is summarized in Table II. One
important conclusion of this experiment is that the presence of
a carboxyl group in the effector is an absolute requirement for
NahR activation. As shown in Table II, salicylamide (compound
FIG. 1. Biodegradation of naphthalene and organization of
LysR-type transcriptional regulators. Naphthalene catabolism by
Pseudomonas strains carrying plasmid NAH7 is determined by two
operons. The upper operon gives rise to the various activities required
for the oxidative transformation of naphthalene into salicylate, whereas
the lower operon determines the subsequent metabolism of this com-
pound onto Krebs cycle intermediates. Transcription of these two oper-
ons requires NahR, a member of the LysR family of regulators (1). The
salicylate produced from naphthalene as the result of the low constitu-
tive expression of the upper operon allows NahR to activate the pro-
moters of both the upper (Pnah) and the lower (Psal) operons through
a positive feedback mechanism (3, 10). Some of the regulatory elements
of the pathway are included in the mini-Tn5 Psal::lacZ and mini-Tn5
nahR/Psal-lacZ transposons shown below the pathway. Their scheme
shows (not to scale) the arrangement of other segments, i.e. Sm or Km
resistance genes, the transcriptional terminator at the end of the lacZ
reporter, and the I and O terminal 19-base pair sequences of the wild
type transposon Tn5. The figure at the bottom summarizes the location
of potential functional domains in LTTRs, which are distributed along
protein sizes of 276–324 amino acids (1, 6), NahR being 300 amino acids
(3). As discussed in the text, the multimerization domain may also
participate in effector recognition.
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B), 2-hydroxy-acetophenone (compound C), and salicyl alcohol
(compound D) caused no accumulation of the reporter product.
On the contrary, substitutions of the 2-hydroxyl group of salic-
ylate were more tolerated, as indicated by the b-galactosidase
activity produced after the addition of anthranilic acid (com-
pound F), o-acetyl-salicylic acid (compound G), or to a lesser
extent o-methoxy-benzoic acid (compound H). However, benzo-
ate (compound E) or 2-chloro-benzoate (compound I) did not
give rise to any significant induction of the reporter system.
Chloro and methyl substituents in positions C-3, C-4, and C-5
of the aromatic ring of salicylate appeared also to be tolerated
(Table II). Introduction of hydroxyl or methoxyl groups in sites
C-4 or C-5 of salicylate decreased the induction ability of the
compounds that were, however, still able to activate NahR to
significant levels. Finally, although with reduced activity, di- or
tri-chloro salicylate derivatives (compounds M and N) could
induce also the reporter system.
In summary, it seems that specific contacts between sub-
stituents of the aromatic ring and the protein engage exclu-
sively positions C-1 and C-2 of the salicylate, the minimal
apparent requirements being the presence of a carboxyl group
in C-1 and the presence of a small functional group with avail-
able electrons in C-2. NahR appeared to accept a wide variety
of salicylate structural analogs as effectors, thus reflecting the
permissiveness of the protein domain(s) that interacts with the
aromatic molecules. The decrease and even lack of activity
observed when bulkier groups are entered in other positions
may reflect a steric hindrance related to the size of the “effector
pocket” in the regulator and not to the disruption of specific
protein-inducer interactions.
Isolation of NahRMutants with Altered Effector Specificity—
Once the structural requirements of NahR effectors were de-
termined, we set out to probe the location of the protein seg-
ments involved in interactions with the aromatic compounds.
We assumed that changes in the amino acid residues involved
in effector recognition may result in NahR variants that can be
activated by otherwise nonproductive inducers. On this basis,
we designed a genetic strategy to identify NahR mutants that
could respond to compounds found to be unable to act as effec-
tors of wild type NahR (Fig. 2). In particular, we pursued the
isolation of mutants responsive to benzoate, because we rea-
soned that NahR variants lacking the interactions with the
quite permissive yet important position C-2 should appear at a
reasonable frequency. To this end, we constructed an E. coli
strain (named E. coli SAL1) bearing a chromosomal Psal::lacZ
fusion, which was used as the recipient of plasmids bearing
mutagenized nahR sequences. With the protocol described un-
der “Materials and Methods,” we first targeted the portion of
NahR spanning amino acids 110–277, corresponding to a DNA
segment of 0.49 kb (Fig. 2). This region was amplified through
error-prone PCR from plasmid pNR. The ligation of the result-
ing BglII-SphI fragment with pNR digested with the same
enzymes was then electroporated in E. coli SAL1 and plated
out on LB/Ap/benzoate/X-Gal plates. After incubation, about
1% of the Ap-resistant colonies were intense blue. In order to
discard constitutive mutants, these blue colonies bearing plas-
mids encoding putative NahR mutants were replicated in LB/
Ap/X-Gal plates with or without benzoate, and only those
clearly regulated by the aromatic compound were kept for
further analysis. This was the case with two-thirds of all colo-
nies tested, i.e. only about one-third of all mutants gave a
constitutive, effector-independent phenotype, whereas the rest
were genuinely responsive to benzoate. In addition, none of the
benzoate-responsive mutants lacked their responsiveness to
salicylate.
Characterization of Benzoate-responsive NahR Variants—
Twenty of the nahR1 pNR derivatives present in E. coli colo-
nies giving a benzoate-responsive color in X-Gal plates were
subjected to DNA sequencing. This revealed the existence of at
least six independent mutations (in all cases single-base tran-
sitions) in the nahR sequence (Fig. 2) accountable for the dis-
tinct phenotype observed. Mutants NahR3 (R248C) and NahR4
TABLE I
Bacteria and plasmids
E. coli K12 strain Relevant genotype/characteristics Reference
CC118 D(ara-leu), araD, DlacX74, galE, galK, phoA 17
CC118lpir CC118 lysogenized with lpir phage 17
S17–1lpir Tpr Smr recA, thi, hsdRM1, RP4<2-Tc<Mu<Km Tn7, lpir phage lysogen 31
SAL1 Smr, CC118 bearing a chromosomal insertion of mini-Tn5 Sm/Psal<lacZ This work
RSL9 Kmr, CC118 bearing a chromosomal insertion of mini-Tn5 nahR/Psal-lacZ This work
R3SL1 Kmr, same as RSL9, but mini-Tn5 nahR/Psal-lacZ insertion bearing mutant nahR3 variant This work
R4SL1 Kmr, same as RSL9, but mini-Tn5 nahR/Psal-lacZ insertion bearing mutant nahR4 variant This work
Plasmids Genotype/phenotype/characteristics Reference
pMS15 Apr, nahR/Psal sequence from NAH7 plasmid of Pseudomonas cloned as a 1.6-kb HindIII-PstI
insert in pUC8
3
pNM482 Apr, 9lacZ promoter probe vector 14
pUJ9 Apr, 9lacZ promoter probe vector, entire fusion excisable as a NotI restriction fragment 15
pUT/mini-Tn5 Sm Apr, Smr, R6KoriV, RP4oriT, mini-Tn5 Sm transposon vector delivery plasmid 15
pTSAL1 Apr, Smr, Psal-nahG9-9lacZ (Psal<lacZ) fusion inserted as a NotI fragment in pUT/mini-Tn5 Sm This work
pFH2 Apr, identical to pBKT7–0 but with NotI sites flanking the multiple cloning site 16
pNR Apr nahR gene cloned as a NcoI-HindIII fragment in pFH2. pNR series (pNR3, pNR4 . . .) encode
nahR variants nahR3, nahR4, etc.
This work
pNR3Km Apr, Kmr, pNR3 inserted with an V-Km interposon at the HindIII site downstream of the nahR3
sequence of pNR
This work
pNR4Km Apr, Kmr, same as pNR3, but bearing nahR4 This work
pUC18Not Apr, same as pUC18 (32) but with NotI sites flanking the multiple cloning site 17
pUC/NRC Apr, pUC18Not inserted with the HindIII/EcoRI segment of pCNB4 (19) bearing the wild type nahR
sequence
This work
pUC/NR Apr, pUC18Not inserted with the wild type nahR gene. pUC/NR series encode numbered nahR
variants
This work
pCNB4 Apr, Kmr, oriR6K, mobRP4, delivery vector for mini-Tn5 nahR/Psal 19
pCNB4lacZ Same as pCNB4, but inserted with a promoterless trp9-9lacZ reporter downstream of the Psal
promoter
19
pCNB43lacZ Same as pCNB4lacZ, but bearing the nahR3 mutant This work
pCNB44lacZ Same than pCNB4lacZ, but bearing the nahR4 mutant This work
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(N169D) bore a single-amino acid change that made the result-
ing proteins to respond to benzoate to the same extent as the
wild type responds to salicylate (Table III). In contrast, mu-
tants NahR5 (M116I), NahR6 (M116T), and NahR8 (M116V)
displayed a remarkably high basal level of activity in the ab-
sence of any inducer, whereas they reached a similar degree of
b-gal accumulation with either benzoate or salicylate (Table
III). This semiconstitutive phenotype was caused in all three
cases by the exchange of the Met116 residue for neutral amino
acids. Mutants NahR3 and NahR4 will be termed hereafter as
variants type I, whereas mutants NahR5, NahR6, and NahR8
will be named variants type II. Interestingly, the same amino
acid change bore by NahR5 was found by Huang and Schell (21)
in their quest for salicylate-independent NahR proteins.
Mutant NahR7 (R132C), albeit similar to type I mutants,
showed an intermediate phenotype because its basal activity
was about twice that of the wild type and its induction by
benzoate was significantly less than its responsiveness to sa-
licylate. However, it gained a remarkable inducibility by other
effectors. In fact, further analysis of the ability of various
compounds to activate mutant NahR variants revealed that
mutants type I and NahR7 (which bear single amino acid
changes) had generally broadened their effector profile while
maintaining a tight regulation. For instance, as indicated in
Table III, NahR3 and NahR7 acquired the ability of being
activated by salicylamide, and they displayed also an enhanced
induction by chloro-derivatives, whereas NahR4 seemed to be
more specific in gain of responsiveness to benzoate. Similarly,
mutants type II generally broadened their effector profile.
FIG. 2. Strategy used for generation of benzoate-responsive
NahR variants. The amino acid sequence of NahR can be matched to
a 0.9-kb DNA sequence that is nearly completely included in an NcoI-
SphI restriction fragment of the NAH7 plasmid (3). Oligonucleotides
flanking the nahR sequence, (excluding the region corresponding to the
DNA-binding protein domain) were employed to prime the region for a
polymerase chain reaction under error-prone conditions. The mu-
tagenized DNA segments were then cloned back to selected plasmids
vectors in order to reconstruct the nahR sequence and transformed in E.
coli SAL1 (Psal::lacZ) to reveal the phenotype of the resulting mutants
(see “Results” for explanation). The lower part of the figure shows the
position within the NahR sequence and the nature of the six benzoate-
responsive mutants described in this work.
TABLE II
Activation of NahR by structural analoges of salicylate
Measured as accumulation of b-galactosidase by E. coli RSL9 (nahR/Psal-lacZ). Figures correspond to Miller units (11) assayed in permeabilized
cells from LB cultures induced for 5 h with 2 mM of each of the compounds indicated (excepting compound M, 3,5-chloro-salicylate, that was added
at 1 mM). The addition of the aromatics to the cultures had no significant effect on growth rate at the concentrations employed. The numbers shown
are the average of three independent assays run with duplicate samples. Positions R1–R6 correspond to the substituents in the aromatic ring.
Compound R1 R2 R3 R4 R5 R6 Inductiona
A -COOH -OH -H -H -H -H 23
B -CONH2 -OH -H -H -H -H 1
C -COCH3 -OH -H -H -H -H 1
D -CH2OH -OH -H -H -H -H 1
E -COOH -H -H -H -H -H 1
F -COOH -NH2 -H -H -H -H 20
G -COOH -OCOCH3 -H -H -H -H 36
H -COOH -OCH3 -H -H -H -H 3
I -COOH -Cl -H -H -H -H 2
J -COOH -OH -Cl -H -H -H 16
K -COOH -OH -H -Cl -H -H 30
L -COOH -OH -H -H -Cl -H 28
M -COOH -OH -Cl -H -Cl -H 9
N -COOH -OH -Cl -H -Cl -Cl 9
O -COOH -OH -CH3 -H -H -H 17
P -COOH -OH -H -CH3 -H -H 19
Q -COOH -OH -H -H -CH3 -H 27
S -COOH -OH -H -H -OCH3 -H 9
T -COOH -OH -OH -H -H -H 9
U -COOH -OH -H -OH -H -H 5
V -COOH -OH -H -H -H -OH 1
a Ratio between maximum accumulation of b-galactosidase and basal enzymatic activity of E. coli RSL9 in the absence of induction (approxi-
mately 50 Miller units).
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However, because these mutants display an up phenotype, it
was difficult to distinguish which compounds became authentic
inducers because of a gain of function in NahR and which
behaved as such because of an unspecific amplification of an
otherwise residual responsiveness. At least in the case of sali-
cylamide and 4 chloro-benzoate, it seems that two of the type II
mutants acquired a genuine ability to respond to these aro-
matic compounds that was totally missing in the wild type
regulator.
Affinity of Group I Mutants for Inducer Compounds—To gain
some insight in the mechanism by which group I mutants
broadened their effector profile, they were subjected to a series
of experiments to compare the apparent affinities of NahR for
four representative effectors, namely salicylate, benzoate,
3-chloro-benzoate and 3-methyl salicylate. To this end, we em-
ployed the procedure developed by Ramos et al. (20) to estimate
in vivo the apparent Ks
9 values of effectors for prokaryotic
transcriptional regulators. The procedure depends on the as-
sumptions that (i) benzoate analogs are transported into E. coli
cell through nonlimiting facilitated diffusion and (ii) the output
of the reporter lacZ fusion reflects faithfully the activity of the
regulator. Because these two conditions can be safely assumed
in our system, we set out to examine the induction of a reporter
Psal-lacZ fusion by varying effector concentrations. In order to
decrease the number of variables in the procedure, we engi-
neered the mutant nahR3 and nahR4 genes along with the
reporter Psal-lacZ fusion within a mini-Tn5 vector (Fig. 1).
These elements, along with that bearing wild type nahR (19),
were introduced into E. coli CC118 by transposition, giving rise
to strains E. coli RSL9 (wild type nahR), E. coli R3SL1
(nahR3), and E. coli R4SL1 (nahR4). As shown in Fig. 3, each
of the strains was subjected to induction experiments with
concentrations of the aromatic compounds ranging from 1025
to 1 mM. It is interesting to note that the fully induced cells
displayed a responsiveness to each of the aromatic compounds
virtually identical to that observed when the reporter system
carries the nahR variants in a multicopy plasmid (Table III).
This ruled out that the phenotypes raised by the nahRmutants
were simply due to different expression levels. On the other
hand, the shape of the dose-response curves in Fig. 3 clearly
indicated that the mutations did increase the affinity of NahR
for specific aromatic compounds. This is particularly true for
benzoate: as shown in Fig. 3C, the affinity increased from
virtually nil to an apparent Ks
9 value in the range of 0.5 mM.
The operative affinities of NahR3 for 3-chloro-benzoate and
3-methyl salicylate increased .100-fold and .10-fold, respec-
tively, as compared with wild type NahR. Interestingly, NahR4
also seemed to remarkably increase its affinity toward salicy-
late. These results suggested that the mutations carried by
NahR variants type I affected amino acid residues involved in
inducer binding.
Benzoate-responsive Multiple Mutants Share the Same Key
Changes in the NahR Sequence—In an attempt to identify
additional residues that could simultaneously be involved in
interactions with the aromatic effectors, we repeated the mu-
tagenesis protocol under conditions in which error-prone PCR
was expected to enter more than one base change per molecule
of amplified DNA (see “Materials and Methods”). Furthermore,
we employed primers NRH5 and NRSph, which amplified a
longer portion of the NahR sequence (Fig. 2) along with plas-
TABLE III
Transcriptional activity of NahR variants induced with various salicylate analoges
Measured as accumulation of b-galactosidase by E. coli SAL1 (Psal-lacZ) transformed with each of the plasmids indicated, encoding the nahR
variants specified in each case.
Plasmid Gene Codon exchanged Amino acidsubstitution
Psal<lacZ activitya
None B 2HB SA 2HBA 2ClB 3ClB 4ClB
Miller units
pNR nahR None None 58 60 1100 106 31 169 483 48
pNR3 nahR3 CGT 3 TGT Arg248 3 Cys 64 923 1499 552 44 837 1008 146
pNR4 nahR4 AAT 3 GAT Asn169 3 Asp 51 1158 1067 71 33 1104 840 40
pNR7 nahR7 CGC 3 TGC Arg132 3 Cys 104 400 1061 1258 61 682 848 186
pNR5 nahR5 ATG 3 ATA Met116 3 Ile 375 1050 1765 1109 330 1526 1303 983
pNR6 nahR6 ATG 3 ACG Met116 3 Thr 359 1101 1247 288 268 1416 1326 949
pNR8 nahR8 ATG 3 GTG Met116 3 Val 432 1049 1419 1330 344 1416 1387 1201
a Units of b-galactosidase (11) assayed in permeabilized cells from LB cultures induced for 5 h with 2 mM of the following inducers: B, benzoate;
2HB, salicylate; SA, salicylamide; 2HBA, 2-OH benzylalcohol; 2ClB, 2-chloro-benzoate; 3ClB, 3-chloro-benzoate; 4ClB, 4-chloro-benzoate.
FIG. 3. Effect of the concentration of aromatic inducers on
Psal activity promoted by NahR and its mutant derivatives.
Wild type nahR and its variants nahR3 and nahR4 were assembled in
mini-Tn5 vectors along with a reporter Psal-lacZ fusion, as explained
under “Materials and Methods.” Strains E. coli RSL9 (wild type
nahR1), E. coli R3SL1 (nahR31), and E. coli R4SL1 (nahR41), bearing
each of the mobile elements in the chromosome (Table I) were then
subjected to induction experiments with varying concentrations of the
aromatic effector indicated in each case: salicylate (A), 3-chloro-benzo-
ate (B), 3-methylsalicylate (C), and benzoate (D). The b-galactosidase
levels determined in permeabilized cells after 5 h of induction are
shown.
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mid pUC/NR (Table I). This facilitated the recovery of the
mutagenized DNA segment. The procedure yielded 47 benzo-
ate-responsive clones. On the basis of their responsiveness to
selected inducers (salicylate, o-acetyl-salicylate, 3-methyl-ben-
zoate, 2,3-chloro-benzoate, 2,6-chloro-benzoate, anthranylate,
5-chloro-salicylate, salicylalcohol, phenol, and salicylamide),
they fell equally (23 and 24 clones) within the two types of
mutants generated with the single-mutation protocol. As before
also, none of the mutants lost its responsiveness to salicylate.
Out of the entire collection, we selected 12 clones displaying a
phenotype of low basal activity and broadening of their effector
profile. All turned out to largely behave as NahR3, NahR4, or
NahR7. Six of these were sequenced. The variant nahR138 was
altered in five bases, three of them producing no amino acid
changes, and the other two causing mutations N125S and
N169D. Two other mutants were found to bear changes in two
bases, both resulting in amino acid exchanges: nahR105 (R248C,
A272T) and nahR141 (M139T,N169D). Finally, two mutants
bore three changed residues: nahR135 (Q158R,N169D,E208G)
and nahR130 (N156S,V226M,R248C), whereas the remaining
one (renamed nahR123) was again, N169D. Therefore, four of
the new six variants had the change N169D, already studied in
nahR4, whereas the other two, alike nahR3, bore the change
R248C. Therefore, the benzoate-responsive effect of the mul-
tiple mutants was attributed to the presence of mutations
already identified and not because of the other amino acid
changes.
DISCUSSION
A number of NahR mutants had been isolated in the past
that could not activate the Psal/Pnah promoters because of
their inability to bind DNA (1, 9). Not surprisingly, some of
these were found to cluster within the the N-terminal portion of
the protein bearing an helix-turn-helix motif (residues 23–45).
However, other nondominant mutants unable to bind DNA
were mapped closer to the C terminus (residues 239–291), thus
suggesting that DNA binding required some multimerization
through a different protein domain (1). In addition, a variety of
noninducible NahR mutants were found within the region
126–206 that were still competent for DNA binding (9). This
central region overlaps also with mutations that led to a con-
stitutive, effector-independent behavior (mapping between res-
idues 99–253; Ref. 21). These data, however, said little on
whether salicylate interacts directly with the protein and, if so,
which parts of the regulator are involved in such an interac-
tion. In this work, we show that mutations that clearly alter
the effector profile of NahR and affect its affinity for aromatic
inducers map recurrently at distict sites of the regulator (Fig.
2). This provides an strong genetic evidence that these sites are
engaged in effector binding during the earlier steps of the
process leading to transcriptional activation of the Psal and
Pnah promoters.
NahR mutants type I and the very related variant NahR7
appear to be genuinely affected in residues that participate in
inducer recognition, because they show an altered effector spec-
ificity without any other detectable phenotypic change. Mu-
tants NahR4 and NahR7 are particularly meaningful in this
respect. As shown in Table III and Fig. 3, NahR4 appeared to
gain the ability to respond to benzoate in a fashion that seemed
to affect only the OH substituent at position C-2 of salicylate.
On the contrary, NahR7 gained a remarkable ability of induc-
tion by salicylamide, suggesting that the protein residue(s)
interacting with the otherwise essential carboxyl group of sa-
licylate have also undergone some change. Mutant NahR3
seems, on the other hand, to increase its general reponsiveness
to virtually all salicylate analogs examined, which may reflect
a flexibilization of the effector pocket in NahR but not so much
the change of a residue directly involved in effector recognition.
Finally, mutants type II pinpoint the pivotal role of amino acid
116 in both effector recognition and NahR activation. That the
mutations in this residue lock the protein in an intermediate
activation step is indicated by the degree of inducer-independ-
ent activity observed. But that the 116 residue may also par-
ticipate in interactions with the carboxyl group of salicylate is
suggested by the observation (Table III) that the changes
M116I and M116V make the proteins respond to salicylamide,
whereas M116T does not. A number of amino acid residues
critical for effector binding are therefore placed in a protein
segment not larger than 60 amino acids, spanning positions
116 and 169. However, the contribution of more distant loca-
tions (i.e. 248) cannot be ruled out. These conclusions generally
fit those found in the OccR protein of Agrobacterium tumefa-
ciens, another archetypical LTTR, in which mutations within
the central portion of OccR (F113L and G148D) increased the
affinity of the protein for its natural effector, octopine (8). Ours
is, however, the first case reported of single mutations within
an LTTR that alter the effector profile of a protein of this type.
It would be highly speculative to draw structural or mecha-
nistic conclusions from the data presented in this work. How-
ever, the remarkable similarity (approximately 50%) between
two segments present in NahR and NodD proteins (residues
140–200 and 207–266; Ref. 3) allows some considerations.
These two regions, which include NahR variants N169D and
R248C, span a potential b-turn-b motif in NodD that might be
a ligand-binding crevice (1, 22). In fact, segments 109–171 and
189–216 of NodD resemble a consensus steroid-binding do-
main, thus suggesting an involvement in effector binding (22).
Furthermore, residue 248 of NahR, which is mutated in variant
nahR3, is located within a region conserved in many LTTRs
that could be involved in multimerization (1). Perhaps the
protein segment around 248 links effector binding to a mul-
timer conformation shift that leads to activation, as has been
suggested for CysB (23).
The ease for obtaining variants with novel effector specific-
ities makes NahR a system of choice for the generation of
proteins responsive to predetermined aromatic molecules, a
task of considerable interest for biotechnological applications
(19, 24–27). In fact, the proneness of NahR to mutate to forms
with a broader effector specificity might not be alien to the fact
that LTTRs are frequently found as regulators of bacterial
operons for biodegradation of xenobiotic compounds (28), the
assembly of which requires a very fast protein evolution (29).
This is true also for the NodD proteins of rhizobia, another well
known case of LTTR, which are necessary for specific interac-
tions with plants (5). NodD proteins must interact with similar
DNA targets (the so-called nod boxes) in response to an array of
flavonoid derivatives present in the plant exudates. The se-
quences available from various NodD proteins indicate that the
ability to recognize novel flavonoids resides in the divergence of
the amino acid sequences of the central protein domains (4, 30).
This substantiates the notion that changes within a few amino
acid residues in LTTRs give rise to repertoires of regulators
responsive to chemical signals that become instrumental for
transcriptional control of many different genes or operons
along evolution (29).
Acknowledgments—We are indebted to M. Schell for various materi-
als used in this study.
REFERENCES
1. Schell, M. A. (1993) Annu. Rev. Microbiol. 47, 597–626
2. Pe´rez-Martı´n, J., Rojo, F., and de Lorenzo, V. (1994) Microbiol. Rev. 58,
268–290
3. Schell, M. A., and Sukordhaman, M. (1989) J. Bacteriol. 171, 1952–1959
4. Appelbaum, E. R., Thompson, D. V., Idler, K., and Chartrain, N. (1988) J.
Bacteriol. 170, 12–20
NahR Specificity Mutants 3991
 at FA
C BIO
LO
G
IA
/BIBLIO
TECA
 on June 7, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
5. Horvath, B., Bachem, C. W. B., Schell, J., and Kondorosi, A. (1987) EMBO J.
6, 841–848
6. Kullik, I., Toledano, M. B., Tartaglia, L. A., and Storz, G. (1995) J. Bacteriol.
177, 1275–1284
7. Burn, J. E., Rossen, L., and Johnston, A. W. B. (1987) Genes & Dev. 1, 456–464
8. Cho, K., and Winans, S. C. (1993) J. Bacteriol. 175, 7715–7719
9. Schell, M. A., Brown, P. H., and Raju, S. (1990) J. Biol. Chem. 265, 3844–3850
10. Schell, M. A., and Poser, E. (1989) J. Bacteriol. 171, 837–846
11. Miller, J. H. (1972) Experiments in Molecular Genetics, Cold Spring Harbor
Laboratory, Cold Spring Harbor, NY
12. Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989) Molecular Cloning: A
Laboratory Manual, 2nd Ed., Cold Spring Harbor Laboratory, Cold Spring
Harbor, NY
13. de Lorenzo, V., and Timmis, K. (1994) Methods Enzymol. 235, 386–405
14. Minton, N. P. (1984) Gene (Amst.) 31, 269–273
15. de Lorenzo, V., Herrero, M., Jakubzik, V., and Timmis, K. (1990) J. Bacteriol.
172, 6568–6572
16. Ferna´ndez, S., de Lorenzo, V., and Pe´rez-Martı´n, J. (1995) Mol. Microbiol. 16,
205–213
17. Herrero, M., de Lorenzo, V., and Timmis, K. (1990) J. Bacteriol. 172,
6557–6567
18. Fellay, R., Frey, J., and Krisch, H. (1987) Gene (Amst.) 52, 147–154
19. de Lorenzo, V., Ferna´ndez, S., Herrero, M., Jakubzik, U., and Timmis, K. N.
(1993) Gene (Amst.) 130, 41–46
20. Ramos, J. L., Michan, C., Rojo, F., Dwyer, D., and Timmis, K. (1990) J. Mol.
Biol. 211, 373–382
21. Huang, J., and Schell, M. A. (1991) J. Biol. Chem. 266, 10830–10838
22. Gyo¨rgypal, Z., and Kondorosi, A. (1991) Mol. Gen. Genet. 226, 337–340
23. Colyer, T. E., and Kredich, N. M. (1994) Mol. Microbiol. 13, 797–805
24. Lehrbach, P. R., Zeyer, J., Reineke, W., Knackmuss, W., and Timmis, K. N.
(1984) J. Bacteriol. 158, 1025–1032
25. Heitzer, A., Webb, O. F., Thonnard, J. E., and Sayler, G. S. S. (1992) Appl.
Environ. Microbiol. 58, 1839–1846
26. Heitzer, A., Malachowsky, K., Thonnard, J. E., Bienkowski, P. R., White, D. C.,
and Sayler, G. S. (1994) Appl. Environ. Microbiol. 60, 1487–1494
27. Yen, K. M. (1991) J. Bacteriol. 173, 5328–5335
28. Van der Meer, J. R., de Vos, W. M., Harayama, S., and Zehnder, A. B. (1992)
Microbiol. Rev. 56, 677–694
29. de Lorenzo, V., and Pe´rez-Martı´n, J. (1996) Mol. Microbiol. 19, 1177–1184
30. Spaink, H. P., Wijffelman, C. A., Okker, R. J., and Lugtenberg, B. J. (1989)
Plant Mol. Biol. 12, 59–73
31. de Lorenzo, V., Eltis, L., Kessler, B., and Timmis, K. (1993) Gene (Amst.) 123,
17–24
32. Yanisch-Perron, C., Viera, J., and J., M. (1985) Gene (Amst.) 33, 103–109
NahR Specificity Mutants3992
 at FA
C BIO
LO
G
IA
/BIBLIO
TECA
 on June 7, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
Angel Cebolla, Carolina Sousa and Víctor de Lorenzo
Inducers
 Define Protein Sites Involved in Binding of AromaticPseudomonasDegrading 
Effector Specificity Mutants of the Transcriptional Activator NahR of Naphthalene
doi: 10.1074/jbc.272.7.3986
1997, 272:3986-3992.J. Biol. Chem. 
  
 http://www.jbc.org/content/272/7/3986Access the most updated version of this article at 
 Alerts: 
  
 When a correction for this article is posted•  
 When this article is cited•  
 to choose from all of JBC's e-mail alertsClick here
  
 http://www.jbc.org/content/272/7/3986.full.html#ref-list-1
This article cites 30 references, 16 of which can be accessed free at
 at FA
C BIO
LO
G
IA
/BIBLIO
TECA
 on June 7, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
